Home/Investors/Janus Henderson Investors

Janus Henderson Investors

Biotech Investor · 8 portfolio companies

Portfolio

8

Focus Areas

11

Top Stage

phase-2

Investment Focus

Metabolic Disorders Gastroenterology Nephrology Oncology Infectious Disease Genetics & Genomics Metabolic Immunology Autoimmune Diseases Endocrinology Rare Disease

Portfolio Companies

Company	Stage	Valuation	Focus
Novome Biotechnologies	phase-2	—	Metabolic Disorders, Gastroenterology
Quanta Therapeutics	phase-1	—	Oncology
CirCode Biomed	phase-1	—	Infectious Disease, Oncology
Eccogene	phase-2	—	Metabolic, Immunology
Parse Biosciences	Commercial	—	—
ProfoundBio	phase-2	—	Oncology
Yarrow Bioscience	Phase 1	—	Autoimmune Diseases, Endocrinology
ADARx Pharmaceuticals	preclinical	—	Genetics & Genomics, Rare Disease

Frequent Co-Investors

OrbiMed2 shared Cormorant Asset Management1 shared Frazier Life Sciences1 shared The Column Group1 shared Mubadala Capital1 shared Boyu Capital1 shared Alpha Wave Ventures1 shared Morningside Ventures1 shared